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Mammalian preimplantation embryos develop along the repro-
ductive tract without direct cell-to-cell contact with oviduct or
uterus until implantation [1]. Although cultured embryos could de-
velop to blastocysts in a simple salt solution, development of cul-
tured mouse embryos is retarded compared with embryos at
comparable stages of development in vivo [2] and the extent of
apoptosis of cultured blastocysts is threefold higher than that of
their in vivo counterparts [3]. Furthermore, reducing the volume
of culture media to increase concentrations of local factors and cul-
turing early embryos in groups improved embryonic development
and reduced apoptosis [4,5]. These ﬁndings suggest that growth
factors derived from early embryos and maternal reproductive
tracts likely play important roles during preimplantation embryo
development [6,7]. Known factors include insulin-like growth fac-
tors [8], epidermal growth factors [4], ﬁbroblast growth factors [9],
and platelet derived growth factors [10].
Artemin, together with GDNF (glial cell line-derived neurotro-
phic factor), persephin, and neurturin are members of the GDNF
family of neurotrophic factors. These proteins are survival factors
for some central and peripheral neurons [11]. Like other memberschemical Societies. Published by E
Hsueh).of the family, artemin signals through a multi-component receptor
system composed of a high-afﬁnity binding component GFRA3 and
a common signaling component RET [12]. Artemin enhances the
survival of early sympathetic neurons, mature superior cervical
ganglion neurons [13], and C-ﬁbres during nerve injury [14].
Although artemin mRNA has been found in peripheral adult and
embryonic tissues [15,16], few studies deal with its physiological
roles in these tissues. We now identiﬁed the co-expression of arte-
min and its receptors in early embryos and demonstrated the abil-
ity of artemin to promote early embryonic cell proliferation and to
suppress apoptosis during in vitro cultures. An autocrine regula-
tory mechanism of the artemin-GFRA3 system was further demon-
strated by using artemin antibodies and soluable ectodomains of
artemin receptors.
2. Materials and methods
2.1. Tissue preparation
Female B6D2F1 mice at 25 days of age (Charles River laborato-
ries, Wilmington, MA) were treated with a single i.p. injection of
7 IU of PMSG (Sigma, St. Louis, MO) followed at 48 h later with
an intraperitoneal injection of 10 IU of human chorionic gonado-
tropin (hCG; American Pharmaceutical Partners, Schaumburg, IL).
After hCG injection, animals were mated with adult males of thelsevier B.V. All rights reserved.
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nate 0.5 day of pregnancy. Pregnant oviducts and uteri were ob-
tained from day 0.5 to day 3.5 of pregnancy and the pregnancy
status was conﬁrmed by recovering embryos from the reproduc-
tive tracts. Animal care was consistent with institutional and Na-
tional Institutes of Health guidelines.
2.2. Embryo cultures
Two-cell stage embryos were ﬂushed from oviducts of mated
mice at day 1.5 of pregnancy (46–47 h after hCG treatment) and
groups of 10 embryos were placed in 50 ll drops of modiﬁed
M16 medium (Chemicon, Temecula, CA) with or without different
doses of artemin (R&D systems, Minneapolis, MN). Some embryos
treated with artemin (15 ng/ml) were also cultured with artemin
antibodies (R&D systems) or non-immune IgG (immunoglobulin).
Fresh medium was replaced every 24 h and embryonic develop-
ment was evaluated after 48, 72, and 96 h of culture to determine
the proportion of embryos at early blastocyst, expanded blastocyst
and hatched blastocyst stages, respectively. To examine the actions
of endogenous artemin on early embryonic development and sur-
vival, 30 two-cell-stage embryos were cultured in 10 ll drops of
modiﬁed M16 medium with or without artemin antibodies. Some
embryos were treated with soluble ectodomains of GFRA3 or RET
fused to the Fc region of IgG (GFRA3-Fc or RET-Fc, R&D systems)artemin GFR
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Fig. 1. Expression of transcripts and proteins for artemin, GFRA3 and RET in preimplanta
in vivo were determined by real-time RT-PCR. All transcript levels were normalized based
early blastocyst; EB: expanded blastocyst; HB: hatched blastocyst. *P < 0.05, **P < 0.01 vs.
signals represent artemin or GFRA3 staining using Alexa Fluor 488-conjugated secondary
secondary antibodies. Embryonic nuclei were stained in blue with Hoechst 33342. (a,
embryos; (d, j, p) morula; (e, k, q) hatched blastocysts; (f, l, r) negative controls using ha
Bar = 50 lm. Insets in k and g represent higher magniﬁcation pictures.and embryonic development was monitored after 48, 72 and
96 h of culture. To evaluate the effects of culture media on the
development of 2-cell embryos, some embryos were also cultured
in KSOMmedia (Chemicon, Temecula, CA) for comparison. In selec-
tive experiments, the ability of artemin to promote early embryo
development starting from the zygote stage was assessed. Embryos
were ﬂushed out of the oviduct at 24 h after hCG treatment and
mating. Zygotes were cultured as described for 2-cell stage em-
bryos to monitor embryonic development at 96 h and 120 h after
culture.
Real-time RT-PCR, immunoﬂuorescence and immunohisto-
chemical analyses, TUNEL staining, and statistical analysis are de-
scribed in Supplementary material.
3. Results
3.1. Temporal and spatial expression of artemin, GFRA3 and RET in
preimplantation embryos
We identiﬁed the co-expression of artemin and its receptors
(GFRA3 and RET) in early embryos based on bioinformatic analyses
of polypeptide ligand–receptor pairs using DNA microarrays [17].
Real-time RT-PCR was performed using embryos obtained
in vivo. Artemin transcripts were expressed in low levels at the
two-cell stage (2C) but increased at the eight-cell stage (8C) afterA3 RET
h
j
n
o
ql
m
p
r
GFRA3 RET
*
*
**
**
**
0
1
2
3
4
5
2C 8C M/B EB HBM/B EB HB
tion embryos. (A) Transcript levels for artemin, GFRA3 and RET in embryos obtained
on those for histone H2a (Mean ± S.E., n = 4). 2C: 2-cell; 8C: 8-cell; M/B: morula and
2C. (B) Localization of artemin, GFRA3 and RET proteins in cultured embryos. Green
antibodies and red signals indicate RET staining using Alexa Fluor 594-conjugated
g, m) two-cell stage embryos; (b, h, n) four-cell stage embryos; (c, i, o) eight-cell
tched blastocysts incubated with non-immune IgGs. Arrowheads indicate ICM cells.
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(M/B) until expanded (EB) and hatched blastocyst stages (HB)
(Fig. 1A). Levels of GFRA3 mRNA were high at the two-cell stage
and increased to its highest level at the eight-cell stage (Fig. 1A),
followed by a decline at the hatched blastocyst stage. Compared
with artemin and GFRA3, RET mRNA levels were lower at the
two- and eight-cell stages but increased at the morula stage until
hatched blastocysts (Fig. 1A).
Artemin, GFRA3 and RET proteins were detected by immunoﬂu-
orescence staining from two-cell embryos to hatched blastocysts
(Fig. 1B, a–f for artemin; g–l for GFRA3; m–r for RET). As shown
in Fig. 1B, a–d, artemin was evenly distributed in the cytoplasm
of blastomeres, whereas GFRA3 (Fig. 1B, g–j) and RET (Fig. 1B,
m–p) were detected on the plasma membrane of blastomeres. As
shown in Fig. 1B, e, although artemin protein was located in both
ICM (inner cell mass) and trophectoderm (TE) cells of hatched blas-
tocyst, stronger staining was detected in ICM cells (arrow). How-
ever, both GFRA3 (Fig. 1B, k) and RET (Fig. 1B, q) proteins were
mainly found in plasma membranes of TE cells (Supplementary
Fig. S1). No signals were found when non-immune IgGs (Fig. 1B,
f, l, r) or pre-absorbed GFRA3 antibodies (data not shown) were
used for staining. These data suggest that artemin produced by
ICM or TE could regulate TE cell function in preimplantation
embryos.
3.2. Expression of artemin, GFRA3 and RET in oviducts
Non-pregnant estrous oviducts (control group) and oviducts
from days 1 to 4 of pregnancy were obtained for real-time PCR0
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Fig. 2. Artemin promotion of the development of cultured preimplantation embryos. Zyg
or with different doses of artemin for 96 h (A) and 120 h (B) to evaluate the proportion
embryos (10 embryos/50 ll culture drop) were cultured with or without artemin for 72
±S.E., nP 10, 100–120 embryos per group.) *P < 0.05, **P < 0.01 as compared with the cont
immune IgG were compared with those treated with artemin alone.analyses. As shown in Fig. S2A (Supplementary material), the high-
est expression of artemin was observed on day 3 of pregnancy.
Also, RET mRNA levels in oviducts increased from day 1 of preg-
nancy. In contrast, negligible GFRA3 transcripts were detected in
oviducts. Immunohistochemical analyses (Fig. S2B) further indi-
cated the expression of artemin in the epithelium of ampulla
(Fig. S2Ba and S2Bb, arrows) but with minimal signals in the isth-
mus (Fig. S2Bc and S2Bd). However, the RET protein was found in
the epithelium of ampulla (Fig. S2Be and S2Bf, arrows) and stroma
of the isthmus (Fig. S2Bg and S2Bh, arrows).
3.3. Artemin treatment promotes preimplantation embryo
development in vitro
We cultured zygotes or two-cell embryos in low density (10
embryos/50 ll microdrop) to investigate the effects of artemin
treatment on early embryonic development. As shown in Fig. 2A,
treatment with artemin promoted the development of zygotes to
the expanded blastocysts after 96 h of culture. Furthermore, a
dose-dependent stimulation of embryonic development to hatched
blastocysts (Fig. 2B) was found at 120 h of culture. Similarly, treat-
ment of cultured two-cell embryos with artemin promoted their
development to expanded blastocysts (Fig. 2C) and hatched blasto-
cysts (Fig. 2D) at 72 h and 96 h, respectively. Artemin, as low as
15 ng/ml, increased the percentages of early embryos reaching
the hatched blastocyst stage. Also, the facilitatory effects of arte-
min on blastocyst hatching could be blocked by cotreatment with
artemin antibodies (Figs. 3B and D), but not by non-immune IgG.
To investigate the effects of culture media, we also cultured two-0
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Fig. 3. Effects of artemin treatment on apoptosis and cell numbers in cultured blastocysts. (A) Detection of apoptotic nuclei by TUNEL staining in blastocysts with or without
artemin (15 ng/ml). Two-cell embryos were cultured for 72 h before analysis. Green, TUNEL-stained nuclei (arrowheads); blue, nuclei counterstained with Hoechst 33342.
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media. As shown in Table 1, artemin promoted the development
of two-cell embryos to expanded and hatched blastocysts under
both culture conditions.
3.4. Effects of artemin treatment on apoptosis and cell number of
cultured blastocysts
Two-cell embryos were collected after 72 h of culture for TUNEL
staining. As shown in Fig. 3A and B, treatment with artemin de-
creased the number of TUNEL-stained nuclei. Nuclei counting
using Hoechst 33342 indicated that artemin treatment increased
total cell numbers of blastocysts compared with the control group,
and increases in cell numbers were preferentially observed in TE
cells (Fig. 3C). The observed effects of artemin were speciﬁc be-
cause increases in cell numbers and decreases in apoptosis afterTable 1
Augmentation of early embryo development in vitro by artemin: comparison of two
different media.
Media Control Artemin
(15 ng/ml)
Artemin
(30 ng/ml)
Expanded
blastocysts (%)
Modiﬁed
M16
70.0 ± 2.5 86.7 ± 3.0a 84.2 ± 3.3a
KSOM 76.7 ± 2.3 86.7 ± 2.3a 90.0 ± 4.0a
Hatched blastocysts
(%)
Modiﬁed
M16
28.7 ± 4.6 47.3 ± 3.7a 47.5 ± 5.2a
KSOM 37.2 ± 3.5 53.3 ± 3.6a 53.3 ± 4.6a
Two-cell stage embryos were cultured with modiﬁed M16 or KSOM media with or
without artemin for 72 h and 96 h before evaluating the percentage of embryos
reaching expanded and hatched blastocyst stages, respectively.
a P < 0.05 vs. controls.artemin treatment were blocked by co-culture with artemin anti-
bodies but not with non-immune IgG (Fig. 3B and C). Treatments
with artemin antibodies or non-immune IgG alone were
ineffective.
3.5. Involvement of the ERK/MAPK pathway in the artemin
suppression of embryo apoptosis
Both ERK/MAPK and PI3K signaling pathways are involved in
regulating the neurotrophic effects of GDNF family members
[11]. Two-cell embryos cultured with artemin were co-treated
with a MEK1/2 inhibitor, U0126 or a PI3K inhibitor LY294002. As
shown in Fig. 4A (upper panel), the MEK1/2 inhibitor U0126, but
not its inactive analog U0124, blocked the artemin suppression of
blastocyst apoptosis at 72 h of culture based on the percentage of
TUNEL-stained nuclei. Furthermore, treatment with U0126
blocked the ability of artemin to increase TE cell numbers
(Fig. 4A, lower panel). In contrast, cotreatment with the PI3K inhib-
itor LY294002 and its inactive analog LY303511 did not alter arte-
min actions (Fig. 4B). To conﬁrm the artemin stimulation of ERK
activation, 8-cell stage embryos were incubated with artemin for
30 min before immunostaining using phospho-ERK antibodies. As
shown in Fig. 4C, b, embryos treated with artemin showed in-
creases in phospho-ERK staining as compared with the untreated
group (Fig. 4C, a). No staining was found in artemin-treated em-
bryos incubated with non-immune IgG (Fig. 4C, c).
3.6. Roles of endogenous artemin during early embryonic development
Because endogenous artemin could be diluted during embryo
cultures, embryos were cultured at a higher density (30 em-
bryos/10 ll) for testing autocrine actions of artemin. As compared
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Fig. 4. Involvement of the ERK/MAPK, but not the PI3 K, pathway in the artemin promotion of embryo survival. (A) Two-cell embryos were cultured without (control) or with
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cell embryos cultured at a higher density showed 20% increase
in the percentage of blastocysts reaching the hatched blastocyst
stage (Fig. 5B and D, control groups). As shown in Fig. 5A and B,
treatment with artemin antibodies, but not non-immune IgG, de-
creased the percentage of two-cell embryos reaching the expanded
and hatched blastocysts at 72 and 96 h of culture, respectively.
Treatment with soluble ectodomains of GFRA1 or RET fused to
the Fc region of IgG antagonized the actions of GDNF in neuro-2a
cells [18]. As shown in Fig. 5C and D, treatment of two-cell em-
bryos with GFRA3-Fc or RET-Fc alone did not affect embryonic
development. However, treatment with both GFRA3-Fc and RET-
Fc suppressed the percentage of embryos reaching the expanded
and hatched blastocysts by 7% and 20% at 72 and 96 h of culture,
respectively. These results suggest an autocrine/paracrine role of
artemin in preimplantation embryos.
4. Discussion
We demonstrated the expression of artemin and its receptors,
GFRA3 and RET, in preimplantation embryos and early pregnant
oviducts. In cultured early embryos, artemin treatment promoted
embryonic development to expanded and hatched blastocyst
stages by differentially increasing TE cell numbers and decreasing
blastocyst cell apoptosis. Furthermore, the ERK/MAPK pathway,
but not the PI3 K pathway, was involved in mediating artemin
actions.
During embryo transit, oviducts produce growth factors to reg-
ulate embryonic development in a paracrine manner [7]. Althoughwe detected artemin and RET in the oviduct, the expression of
GFRA3 was negligible as previously reported [16]. Immunostaining
analyses further indicated that artemin proteins are expressed in
the epithelium of oviduct ampulla, in which fertilization and early
embryonic development occurs [19]. These data suggest a poten-
tial paracrine role of oviductal artemin in preimplantation embryo
development. Although RET was also expressed in oviductal am-
pulla and isthmus, artemin produced by embryos is unlikely to reg-
ulate oviductal functions due to minimal oviductal expression of
GFRA3.
A number of paracrine/autocrine factors regulate embryonic
development as reﬂected by changes in cell number, energy
metabolism, and apoptosis of blastocysts [7,20]. After artemin
treatment, we observed dramatic increases in the percentages of
cultured zygotes or two-cell embryos developing into blastocysts,
thus demonstrating the important role of artemin. We hypothe-
sized that endogenous artemin and other paracrine factors re-
leased by embryos during culture are diluted in the culture
medium based on a higher developmental potential of embryos
cultured in high density [5]. In a high density culture system (30
embryos/10 ll culture medium), treatment with artemin antibod-
ies and soluble ectodomains of GFRA3 and RET receptors sup-
pressed embryonic development, presumably by blocking the
actions of endogenous artemin. The present ﬁndings suggested
an autocrine/paracrine action of artemin secreted by early
embryos.
Artemin treatment increased the overall number of embryonic
cells through a differential increase in TE cells. These ﬁndings are
consistent with the distribution of GFRA3 and RET in TE cells and
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2484 J. Li et al. / FEBS Letters 583 (2009) 2479–2485suggest a potential role of artemin in facilitating embryonic
implantation and placentation. GDNF family members, including
artemin, support cell survival in central or peripheral neurons
[11,14]. Our study further demonstrate the role of artemin as a sur-
vival factor for preimplantation embryos. Apoptosis occurs as a
normal physiological process during preimplantation embryogene-
sis [3]. Although mouse embryos in serum-free cultures showed
increases in apoptosis, inclusion of selected growth factors in the
culture medium suppressed apoptosis [7]. Artemin stimulation of
cell numbers and suppression of apoptosis in blastocysts suggest
that inclusion of artemin provides an optimal environment for cul-
turing early embryos. Both MAPK and PI3K pathways participate in
preimplantation embryonic development [21,22]. Artemin, like
other members of GDNF family, triggers neuroprotective actions
via the ERK/MAPK-dependent pathway in dorsal root ganglia neu-
rons [23] and retinal glial cells [24]. We demonstrated the involve-
ment of the MEK/ERK pathway, but not the PI3K pathway, in the
artemin promotion of cell survival during preimplantation embry-
onic development.
Both artemin and GFRA3 null mice showed abnormalities in
the sympathetic nervous system [25]. Mice homozygous for a
targeted mutation in RET developed to term, but died soon after
birth, showing renal agenesis [26]. Although some of these null
mice were viable, no studies evaluated possible abnormalities
during preimplantation development. GDNF, closely related to
artemin, regulates ureteric branching and spermatogonial stem
cell self-renewal [27,28]. Of interest, culturing mouse embryos
with GDNF also promoted blastocyst expansion and hatching
[29]. The ability of artemin or GFRA3 null mice to develop to
term may be due to the overlapping actions of GDNF family
members on preimplantation embryos. In conclusion, our resultsdemonstrate an autocrine/paracrine role of artemin during
preimplantation embryo development. Inclusion of artemin is
useful in designing optimal cultures for animal and human
embryos.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2009.06.050.
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